Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India

Abstract India’s lockdown and subsequent restrictions against SARS-CoV-2, if lifted without any other mitigations in place, could risk a second wave of infection. A test-and-isolate strategy, using PCR diagnostic tests, could help to minimise the impact of this second wave. Meanwhile, population-lev...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sandip Mandal, Hemanshu Das, Sarang Deo, Nimalan Arinaminpathy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/11267fafebd340dd96d66521fc4387be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11267fafebd340dd96d66521fc4387be
record_format dspace
spelling oai:doaj.org-article:11267fafebd340dd96d66521fc4387be2021-12-02T10:49:16ZCombining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India10.1038/s41598-021-81405-22045-2322https://doaj.org/article/11267fafebd340dd96d66521fc4387be2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81405-2https://doaj.org/toc/2045-2322Abstract India’s lockdown and subsequent restrictions against SARS-CoV-2, if lifted without any other mitigations in place, could risk a second wave of infection. A test-and-isolate strategy, using PCR diagnostic tests, could help to minimise the impact of this second wave. Meanwhile, population-level serological surveillance can provide valuable insights into the level of immunity in the population. Using a mathematical model, consistent with an Indian megacity, we examined how seroprevalence data could guide a test-and-isolate strategy, for fully lifting restrictions. For example, if seroprevalence is 20% of the population, we show that a testing strategy needs to identify symptomatic cases within 5–8 days of symptom onset, in order to prevent a resurgent wave from overwhelming hospital capacity in the city. This estimate is robust to uncertainty in the effectiveness of the lockdown, as well as in immune protection against reinfection. To set these results in their economic context, we estimate that the weekly cost of such a PCR-based testing programme would be less than 2.1% of the weekly economic loss due to the lockdown. Our results illustrate how PCR-based testing and serological surveillance can be combined to design evidence-based policies, for lifting lockdowns in Indian cities and elsewhere.Sandip MandalHemanshu DasSarang DeoNimalan ArinaminpathyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sandip Mandal
Hemanshu Das
Sarang Deo
Nimalan Arinaminpathy
Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
description Abstract India’s lockdown and subsequent restrictions against SARS-CoV-2, if lifted without any other mitigations in place, could risk a second wave of infection. A test-and-isolate strategy, using PCR diagnostic tests, could help to minimise the impact of this second wave. Meanwhile, population-level serological surveillance can provide valuable insights into the level of immunity in the population. Using a mathematical model, consistent with an Indian megacity, we examined how seroprevalence data could guide a test-and-isolate strategy, for fully lifting restrictions. For example, if seroprevalence is 20% of the population, we show that a testing strategy needs to identify symptomatic cases within 5–8 days of symptom onset, in order to prevent a resurgent wave from overwhelming hospital capacity in the city. This estimate is robust to uncertainty in the effectiveness of the lockdown, as well as in immune protection against reinfection. To set these results in their economic context, we estimate that the weekly cost of such a PCR-based testing programme would be less than 2.1% of the weekly economic loss due to the lockdown. Our results illustrate how PCR-based testing and serological surveillance can be combined to design evidence-based policies, for lifting lockdowns in Indian cities and elsewhere.
format article
author Sandip Mandal
Hemanshu Das
Sarang Deo
Nimalan Arinaminpathy
author_facet Sandip Mandal
Hemanshu Das
Sarang Deo
Nimalan Arinaminpathy
author_sort Sandip Mandal
title Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
title_short Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
title_full Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
title_fullStr Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
title_full_unstemmed Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
title_sort combining serology with case-detection, to allow the easing of restrictions against sars-cov-2: a modelling-based study in india
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/11267fafebd340dd96d66521fc4387be
work_keys_str_mv AT sandipmandal combiningserologywithcasedetectiontoallowtheeasingofrestrictionsagainstsarscov2amodellingbasedstudyinindia
AT hemanshudas combiningserologywithcasedetectiontoallowtheeasingofrestrictionsagainstsarscov2amodellingbasedstudyinindia
AT sarangdeo combiningserologywithcasedetectiontoallowtheeasingofrestrictionsagainstsarscov2amodellingbasedstudyinindia
AT nimalanarinaminpathy combiningserologywithcasedetectiontoallowtheeasingofrestrictionsagainstsarscov2amodellingbasedstudyinindia
_version_ 1718396571803975680